{
    "title": "U.S. pauses new patients on Merck MS drug in blow to shares",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11964023/U-S-pauses-new-patients-Mercks-MS-drug-shares-dive.html",
    "date": "2023-04-12",
    "keywords": [
        "drug",
        "merck",
        "fda",
        "study",
        "initiation",
        "sclerosis",
        "race",
        "class",
        "decision",
        "phase",
        "recruitment",
        "trial",
        "berlin",
        "kgaa",
        "wednesday",
        "food",
        "administration",
        "share",
        "price",
        "kinase",
        "btk",
        "progression",
        "nerve",
        "disease",
        "tolerability",
        "concern",
        "gmt",
        "slid",
        "bottom",
        "bluechip",
        "dax",
        "index",
        "news",
        "setback",
        "response",
        "laboratory",
        "injury",
        "iii",
        "discontinuation",
        "medication",
        "path",
        "forward",
        "benefit",
        "evobrutinib",
        "statement",
        "company",
        "data",
        "quarter",
        "candidate",
        "tolebrutinib",
        "takeover",
        "principia",
        "biopharma",
        "hold",
        "june",
        "liver",
        "development",
        "novartis",
        "reporting",
        "rachel",
        "burger",
        "patricia",
        "weiss",
        "editing",
        "heine",
        "emelia",
        "sitholematarise",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}